For members enrolled in an IBC prescription drug program, prior authorization requirements will be applied to certain drugs. The purpose of prior authorization is to ensure that drugs are medically necessary and are being used appropriately. The most recent updates are reflected below.

Drugs requiring prior authorization

The prior authorization requirement for the following non-formulary drugs was effective at the time the drugs became available in the marketplace: Brand drug Generic drug Drug category Effective date Edarbyclor^TM Not available Heart, Blood Pressure, & Cholesterol February 13, 2012 Erivedge^TM Not available Cancer & Organ Transplant February 13, 2012 Inlyta^® Not available Cancer & Organ Transplant February 13, 2012 Jentadueto^TM Not available Diabetes, Thyroid, Steroids, & Other Misc Hormones February 17, 2012 Kalydeco^TM Not available Diagnostic & Miscellaneous Agents February 24, 2012 Picato^® Not available Skin Medication March 9, 2012